Breast/ovarian cancer
31 – 40 of 143
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
SUMO-specific proteases : SENPs in oxidative stress-related signaling and diseases
- Contribution to journal › Scientific review
-
Mark
A Versatile and Upgraded Version of the LundTax Classification Algorithm Applied to Independent Cohorts
- Contribution to journal › Article
-
Mark
Longitudinal molecular profiling elucidates immunometabolism dynamics in breast cancer
- Contribution to journal › Article
-
Mark
Kataegis in clinical and molecular subgroups of primary breast cancer
(2024) European Association for Cancer Research
- Contribution to conference › Poster
-
Mark
Tisotumab Vedotin as Second- or Third-Line Therapy for Recurrent Cervical Cancer
- Contribution to journal › Article
-
Mark
Safe to save blood in ovarian cancer surgery : time to change transfusion habits
- Contribution to journal › Article
-
Mark
Regulation of estrogen receptor alpha by promoter methylation, alternative splicing and microRNA
(2024) In Lund University, Faculty of Medicine Doctoral Dissertation Series
- Thesis › Doctoral thesis (compilation)
-
Mark
Has time to chemotherapy from primary debulking surgery in advanced ovarian cancer an impact on survival? - A population-based nationwide SweGCG study
- Contribution to journal › Article
-
Mark
Kataegis in clinical and molecular subgroups of primary breast cancer
- Contribution to journal › Article
-
Mark
An integrated omics approach highlights how epigenetic events can explain and predict response to neoadjuvant chemotherapy and bevacizumab in breast cancer
- Contribution to journal › Article
